Department of Epidemiology and Biostatistics 3rd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Pritchard E., Matthews P.C., Stoesser N. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat Med. 2021;27:1370–1378. PubMed PMC

Wilkins J.T., Hirschhorn L.R., Gray E.L. Serologic status and SARS CoV-2 infection over 6-months of follow-up in healthcare workers in Chicago: A cohort study. Infect Control Hosp Epidemiol. 2021 Aug 9 [Epub ahead of print] PubMed PMC

Hansen C.H., Michlmayr D., Gubbels S.M. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: A population-level observational study. Lancet. 2021;397:1204–1212. PubMed PMC

Sheehan M.M., Reddy A.J., Rothberg M.B. Reinfection rates among patients who previously tested positive for COVID-19: A retrospective cohort study. Clin Infect Dis. 2021 ciab234. PubMed PMC

Letizia A.G., Ge Y., Vangeti S. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: A prospective cohort study. Lancet Respir Med. 2021;9:712–720. PubMed PMC

Hall V.J., Foulkes S., Charlett A. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: A large, multicentre, prospective cohort study (SIREN) Lancet. 2021;397:1459–1469. PubMed PMC

Abo-Leyah H., Gallant S., Cassidy D. The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers. ERJ Open Res. 2021;7 00080-2021. PubMed PMC

Lumley S.F., Rodger G., Constantinides B. An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status. Clin Infect Dis. 2021:ciab608. PubMed PMC

Lumley S.F., O'Donnell D., Stoesser N.E. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. 2021;384:533–540. PubMed PMC

Pilz S., Chakeri A., Ioannidis J.P. SARS-CoV-2 re-infection risk in Austria. Eur J Clin Invest. 2021;51:e13520. PubMed PMC

Vitale J., Mumoli N., Clerici P. Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Intern Med. 2021:e212959. PubMed PMC

Leidi A., Koegler F., Dumont R. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021:ciab495. PubMed PMC

Breathnach A.S., Riley P.A., Cotter M.P. Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months. J Infect. 2021;82:e11–e12. PubMed PMC

Manica M., Pancheri S., Poletti P. The risk of symptomatic reinfection during the second COVID-19 wave in individuals previously exposed to SARS-CoV-2. medRxiv. Apr 20 2021 doi: 10.1101/2021.04.14.21255502. DOI

Hanrath A.T., Payne B.A.I., Duncan C.J.A. Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection. J Infect. 2021;82:e29–e30. PubMed PMC

Guthmiller J.J., Stovicek O., Wang J. SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike. mBio. 2021;12 e02940-20. PubMed PMC

Salcher-Konrad M., Smith S., Comas-Herrera A. Emerging evidence on effectiveness of COVID-19 vaccines among residents of long-term care facilities. J Am Med Dir Assoc. 2021;22:1602–1603. PubMed PMC

The Effectiveness of Post-Vaccination and Post-Infection Protection in the Hospital Staff of Three Prague Hospitals: A Cohort Study of 8-Month Follow-Up from the Start of the COVID-19 Vaccination Campaign (COVANESS)